Argenica Therapeutics Ltd Financial Flexibility Index
Argenica Therapeutics Ltd financial flexibility index. Argenica Therapeutics Ltd (AGN) has a Financial Flexibility Index of -3.14x as of December 2025. Free cash flow of AU$-5.51 Million (operating CF AU$-5.51 Million minus capex AU$0.00) represents -3% of total liabilities (AU$1.76 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Argenica Therapeutics Ltd (2019–2024)
Financial flexibility index of Argenica Therapeutics Ltd from 2019 to 2024. Historical Financial Flexibility Index trend for Argenica Therapeutics Ltd across 6 annual periods. Check Argenica Therapeutics Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Argenica Therapeutics Ltd Financial Flexibility Index by Year (2019–2024)
Argenica Therapeutics Ltd financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Argenica Therapeutics Ltd. For the full cash flow conversion analysis, see AGN cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.50x | AU$-5.70 Million | AU$-5.70 Million | AU$3.80 Million | — |
| 2023 | 0.00x | AU$0.00 | AU$-5.06 Million | AU$2.43 Million | ▲ +100.0% |
| 2022 | -1.76x | AU$-3.30 Million | AU$-3.30 Million | AU$1.87 Million | ▲ +61.5% |
| 2021 | -4.57x | AU$-3.36 Million | AU$-3.36 Million | AU$735.91K | ▼ -85.8% |
| 2020 | -2.46x | AU$-1.05 Million | AU$-1.05 Million | AU$425.72K | ▼ -1401.4% |
| 2019 | -0.16x | AU$-58.82K | AU$-58.82K | AU$359.26K | — |